Verona Pharma Plc ADR (NASDAQ:VRNA) price is hovering higher on current market day and jumping 4.67% above its previous close.
A look at today’s price movement shows that the recent level at last check reads $86.78. Taking into account the 52-week price action we note that the stock hit a 52-week high of $87.73 and 52-week low of $12.20. The stock added 34.50% on its value in the past month.
Verona Pharma Plc ADR, which has a market valuation of $7.73 billion, is expected to release its quarterly earnings report in July.
Technical indicators in stocks provide crucial insights into market trends, guiding investors with precise entry and exit points based on price movements for informed decision-making.
Here is a look at the average analyst rating for the stock as represented on a scale of 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock is strong buy or strong sell respectively. Specifically, 7 analysts have assigned VRNA a recommendation rating as follows: 0 rate it as a Hold; 7 advise Buy while 0 analyst(s) assign an Overweight rating. 0 analyst(s) have tagged the Verona Pharma Plc ADR (VRNA) stock as Underweight, with 0 recommending Sell. In general, analysts have rated the stock Buy, a scenario likely to bolster investors out for an opportunity to add to their holdings of the company’s shares.
The overview shows that VRNA’s price is at present 15.67% off the SMA20 and 31.12% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 77.51, with weekly volatility standing at 1.74%. The indicator jumps to 2.15% when calculated based on the past 30 days. Verona Pharma Plc ADR (NASDAQ:VRNA)’s beta value is holding at 0.22, while the average true range (ATR) indicator is currently reading 3.34. Considering analysts have assigned the stock a price target range of $74-$83 as the low and high respectively, we find the trailing 12-month average consensus price target to be $77.5. Based on this estimate, we see that today’s price at last check is roughly 18.53% off the estimated low and 8.62% off the forecast high. Investors will no doubt be excited to see the share price rise to $77.5, which is the median consensus price, and at that level VRNA would be 14.68% from recent price.
An analysis of the Verona Pharma Plc ADR (NASDAQ:VRNA) stock in terms of its daily trading volume indicates that the 3-month average is 1.40 million.
Current records show that the company has 85.13M in outstanding shares. The insiders’ percentage holdings are 9.90% of outstanding shares while the percentage share held by institutions stands at 76.23%. But the 95.59% upside, the stock’s price has registered year-to-date as of today’s value, will likely reignite investor interest given the prospect of it rallying even higher.
